246 related articles for article (PubMed ID: 12039934)
1. Decision-analytic model and cost-effectiveness evaluation of postmastectomy radiation therapy in high-risk premenopausal breast cancer patients.
Lee JH; Glick HA; Hayman JA; Solin LJ
J Clin Oncol; 2002 Jun; 20(11):2713-25. PubMed ID: 12039934
[TBL] [Abstract][Full Text] [Related]
2. Subgroup Economic Evaluation of Radiotherapy for Breast Cancer After Mastectomy.
Wan X; Peng L; Ma J; Chen G; Li Y
Clin Ther; 2015 Nov; 37(11):2515-2526.e5. PubMed ID: 26475419
[TBL] [Abstract][Full Text] [Related]
3. A cost-outcome analysis of adjuvant postmastectomy locoregional radiotherapy in premenopausal node-positive breast cancer patients.
Dunscombe P; Samant R; Roberts G
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):977-82. PubMed ID: 11072153
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of routine radiation therapy following conservative surgery for early-stage breast cancer.
Hayman JA; Hillner BE; Harris JR; Weeks JC
J Clin Oncol; 1998 Mar; 16(3):1022-9. PubMed ID: 9508186
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of adjuvant trastuzumab in human epidermal growth factor receptor 2-positive breast cancer.
Liberato NL; Marchetti M; Barosi G
J Clin Oncol; 2007 Feb; 25(6):625-33. PubMed ID: 17308267
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer.
Garrison LP; Lubeck D; Lalla D; Paton V; Dueck A; Perez EA
Cancer; 2007 Aug; 110(3):489-98. PubMed ID: 17592827
[TBL] [Abstract][Full Text] [Related]
7. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of intraoperative radiation therapy for early-stage breast cancer.
Alvarado MD; Mohan AJ; Esserman LJ; Park CC; Harrison BL; Howe RJ; Thorsen C; Ozanne EM
Ann Surg Oncol; 2013 Sep; 20(9):2873-80. PubMed ID: 23812769
[TBL] [Abstract][Full Text] [Related]
9. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results.
Hillner BE; Smith TJ; Desch CE
JAMA; 1992 Apr; 267(15):2055-61. PubMed ID: 1552641
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of zoledronic acid plus endocrine therapy in premenopausal women with hormone-responsive early breast cancer.
Delea TE; Taneja C; Sofrygin O; Kaura S; Gnant M
Clin Breast Cancer; 2010 Aug; 10(4):267-74. PubMed ID: 20705558
[TBL] [Abstract][Full Text] [Related]
14. Postmastectomy radiation and survival in older women with breast cancer.
Smith BD; Haffty BG; Hurria A; Galusha DH; Gross CP
J Clin Oncol; 2006 Oct; 24(30):4901-7. PubMed ID: 17050874
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Sofrygin O; Thomas SK; Papo NL; Barghout V
Clin Breast Cancer; 2007 Jun; 7(8):608-18. PubMed ID: 17592673
[TBL] [Abstract][Full Text] [Related]
16. Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients.
Shi Z; Peddi P; Burton G; Mills G; Shi R
Anticancer Res; 2016 Jan; 36(1):261-9. PubMed ID: 26722052
[TBL] [Abstract][Full Text] [Related]
17. Postmastectomy radiation therapy in T3 node-negative breast cancer.
Elmore L; Deshpande A; Daly M; Margenthaler JA
J Surg Res; 2015 Nov; 199(1):90-6. PubMed ID: 25976852
[TBL] [Abstract][Full Text] [Related]
18. Partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer: a cost-effectiveness analysis.
Sher DJ; Wittenberg E; Suh WW; Taghian AG; Punglia RS
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):440-6. PubMed ID: 18963542
[TBL] [Abstract][Full Text] [Related]
19. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women.
Shirvani SM; Pan IW; Buchholz TA; Shih YC; Hoffman KE; Giordano SH; Smith BD
Cancer; 2011 Oct; 117(20):4595-605. PubMed ID: 21710653
[TBL] [Abstract][Full Text] [Related]
20. Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease : An individual patient data analysis of three clinical trials.
Abdel-Rahman O
Strahlenther Onkol; 2019 Apr; 195(4):297-305. PubMed ID: 30069737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
